|
⚲
|
| Keyboard |
| Cohen Marc A
✚
|
|
|---|---|
| CIK # | 0001132945 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001132945] | |
| 4 | [0001132945] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cohen Marc A | |
| Korro Bio Inc | |
| C4 Therapeutics Inc | |
| Opnet Technologies Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2022-06-22 | Grant | 23,500 | $0.00 | |
|
Korro Bio Inc FREQ
Stock Option · derivative
|
2022-06-21 | Grant | 14,846 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2022-01-04 | Grant | 657 | $31.58 | 20,748 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2021-10-04 | Grant | 461 | $44.99 | 20,740 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2021-07-02 | Grant | 522 | $39.72 | 20,734 |
|
Korro Bio Inc FREQ
Stock Option · derivative
|
2021-06-17 | Grant | 14,846 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2021-06-15 | Grant | 23,500 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2021-06-14 | Other | 92,817 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2021-06-14 | Other | 22,598 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2021-04-05 | Grant | 553 | $37.51 | 20,743 |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2021-02-18 | Option exercise | 536 | $2.11 | 1,131 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2021-02-18 | Option exercise | 536 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2020-10-06 | Conversion | 2,484,425 | ||
|
C4 Therapeutics Inc CCCC
Series A Preferred Stock · derivative
|
2020-10-06 | Conversion | 12,500,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Series Seed Preferred Stock · derivative
|
2020-10-06 | Conversion | 2,000,000 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2020-10-06 | Conversion | 237,149 | ||
|
C4 Therapeutics Inc CCCC
Common Stock
|
2020-10-06 | Conversion | 1,482,183 | ||
|
C4 Therapeutics Inc CCCC
Series B Preferred Stock · derivative
|
2020-10-06 | Conversion | 20,952,403 | $0.00 | |
|
C4 Therapeutics Inc CCCC
Common Stock
|
2020-10-06 | Buy | 5,030 | $19.00 | 95,570 |
|
C4 Therapeutics Inc CCCC
Stock Option (Right to Buy) · derivative
|
2020-10-01 | Grant | 17,786 | $0.00 | |
| showing 20 of 53 most recent transactions | |||||